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Abstract: 23
Plasmodium falciparum gametocytes are not associated with clinical symptoms but they are 24 responsible for transmitting the pathogen to mosquitoes. Therefore gametocytocidal 25 interventions are important for malaria control and resistance containment but currently 26 available drugs and vaccines are not well suited for that purpose. Several dyes have potent 27
antimicrobial activity but their use against gametocytes has not been investigated 28
systematically. 29
Gametocytocidal activity of nine synthetic dyes and four compounds with known activity was 30 tested against stage V gametocytes of the laboratory strain 3D7 and three clinical isolates of P. 31 falciparum with a bioluminescence assay. 32
Five of the fluorescent dyes had 50% inhibitory concentration (IC 50 ) values at sub-micromolar 33 concentration against mature gametocytes. Three mitochondrial dyes: MitoRed, DiOC6 and 34 rhodamine B were highly active (IC 50 < 200 nM). MitoRed showed the highest activity against 35 gametocytes with an IC 50 of 70 nM against 3D7 and 120-210 nM against clinical isolates. All 36 compounds were more active in the laboratory strain 3D7 in comparison with clinical isolates. 37
In particular, the endoperoxides artesunate and dihydroartemisinin showed a 10-fold higher 38 activity in 3D7 compared to clinical isolates. 39
In contrast to all clinically used antimalarials, several fluorescent dyes had a surprisingly high in 40 vitro activity against late stage gametocytes. Since they also act against asexual blood stages, 41
Introduction 47
Malaria leads to approximately one million deaths annually and remains a highly relevant public 48 health problem in tropical and sub-tropical regions (1) . Plasmodium falciparum, the most 49 virulent species, is responsible for most of the malaria morbidity and accounts for almost all 50 malaria mortality in Sub-Saharan Africa. Gametocytes are the stage responsible for 51 transmission of the parasite from the human host to the mosquito. During the asexual blood 52 stage, a small fraction of parasites differentiates into gametocytes. In P. falciparum 53 differentiation occurs within 8-14 days in internal organs, mainly in bone marrow (2-4), from 54 sequestered immature (stage I-IV) to free circulating mature stages (stage V). When a 55 mosquito takes a blood meal it ingests stage V male and female gametocytes, which can 56 further develop in the mosquito. In the mosquito gut, gametocytes develop into gametes that 57 join to become a zygote which then matures into the ookinete followed by the oocyst stage. 58
This stage gives rise to sporozoites, which are released from the oocyst and migrate to the 59 salivary glands of the mosquito where they can be transmitted during a subsequent blood meal. 60
Even though gametocytes are essential for the spread of malaria, transmission-blocking agents 61
have not been a priority in the search of antimalarial drugs for a long time. This has recently 62 changed with the ambition to eradicate malaria (5). On the Malaria Eradication Research 63 Agenda (malERA) development of a new generation of transmission blocking tools and 64 therapies is a top priority since they are believed to be essential for the elimination and 65 subsequent eradication of malaria (6,7). 66
Most current antimalarial drugs show at most, only modest activity against early gametocytes 67 but have either negligible or no effect on stage V gametocytes, although all are active against 68 the asexual blood stage parasites (8-10) and some inhibit growth of pre-erythrocytic stages.strain 3D7 and three clinical isolates from Lambaréné, Gabon with an established 94 bioluminescence assay (8). 95
Materials and Methods 96

Cultivation of asexual parasites 97
The P. falciparum strain 3D7 (Malaria Research and Reference Reagent Resource, ATCC, 98
Virginia, USA) and clinical isolates obtained from Lambaréné, Gabon were kept in continuous 99 culture as described earlier (26). Clinical isolates were from a study reported previously (27) . 100
Blood was sampled directly from patients with P. falciparum mono-infection and cryopreserved 101 in glycerolyte at -150°C until culture for the experiment was initiated. The cultures of both 3D7 102 and clinical isolates were kept at 5% hematocrit in complete culture medium (RPMI 1640 103 supplemented with 25 mM HEPES, 28 mM NaHCO 3 , 50 μg/mL gentamycine, 0.5% w/v 104 Albumax II, 2.4 mM L-glutamine, and 0.14 mM hypoxanthine at 5% CO 2 and 5% O 2 ). For 105 clinical isolates 5% human serum was added to the complete culture medium. Medium was 106 replaced every 24 hours. 107
Gametocyte culture and purification 108
Gametocyte culture was performed as described previously (8) with some modifications. 109
Cultures were started from asexual parasites kept in continuous culture with sorbitol 110 synchronization twice weekly (28). Culture medium for gametocytes always contained 5% 111 human serum. Initially, the culture was adjusted to 9% hematocrit and 0.5% parasitemia and 112 kept at 5% O 2 /CO 2 at 37 o C with daily change of medium without parasite dilution for two weeks. 113
In the second week, the volume of medium was doubled and cultures were treated with 50 mM 114 N-acetyl-D-glucosamine (MP Biomedicals GmbH, Santa Ana, CA, USA) for four days 115 beginning 11 days after initiation to remove asexual parasites. To enrich stage V gametocytes 116 from approximately 2% to over 90% a two-step purification was performed on day 15 using a 117 on July 6, 2017 by guest http://aac.asm.org/ Downloaded from NycoPrep 1.077 cushions density gradient (Axis-Shield PoC AS, Oslo, Norway) followed by 118 magnetic separation with LD-MACS magnetic columns (Miltenyi Biotec, Gladbach, Germany) 119 to remove remaining erythrocytes. Purification was done at 37°C to keep gametocytes viable 120 and avoid exflagellation during the procedure. 121
Viability of mature gametocytes after separation 122
Viability of gametocytes after purification was assessed by microscopy ( Figure 1 ) and the 123 capacity of male gametocyte to exflagellate in exflagellation medium (complete culture medium 124 with 5% human serum and 100 µM xanthurenic acid) for 20 minutes at room temperature as 125 described earlier (25, 29) . 126
Compounds 127
We selected eight fluorescent dyes (see structures in Methylene blue and acridine orange were dissolved in water, while all other tested dyes were 143 dissolved in DMSO. Further dilutions were done with complete culture medium. Final DMSO 144 concentrations were less than 0.5%, a concentration that does not interfere with gametocyte 145
viability. 146
Epoxomicin was used as a positive control as it is a potent inhibitor of all clinically relevant 147 parasite stages including gametocytes in vitro. 148
ATP-based bioluminescence assay 149
We used a bioluminescence assay based on the luciferin-luciferase adenosine triphosphate 150 (ATP)-dependent reaction to assess activity of the different compounds against mature 151
gametocytes. 152
The assay was performed as previously described with some modifications (8,30). In brief, 153 compounds were three-fold serially diluted in a 96-well plate. After purification, gametocytes 154 were counted microscopically using an Improved Neubauer Cell counting chamber and 5x10 4 155 purified stage V gametocytes were added to each well in a final volume of 100 µL. In order to 156 validate the test protocol and determine the linear relationship between ATP content and 157 number of gametocytes in culture medium, we generated a standard curve using a two-fold 158 serial dilution of 50,000 purified mature gametocytes. On every plate a serial dilution of viable 159 stage V gametocytes was added as a control. 160 ATP measurements were done using equal volumes (50 µL) of gametocyte culture and 161
BacTiterGlo reagent (Promega, Mannheim, Germany) in white opaque-walled 96-well plates, 162 incubated at room temperature in the dark for 5 min to allow cell lysis and stabilization of the 163 on July 6, 2017 by guest http://aac.asm.org/ Downloaded from luminescent signal. Subsequently, the luminescence signal was recorded with a luminometer 164 (LUMO, Anthos Microsysteme, Krefeld, Germany). 165
Stage V gametocytes were exposed to serial dilutions of the test compounds for 24 hours or 48 166 hours to assess the effect of incubation time on the activity. Experiments using 3D7 and 48 167 hours incubation time were performed at least three times independently. 168
Statistical analysis 169
We used the drc-package version 2.3.7 of R version 2.15.1 to calculate the inhibitory 170 concentrations of compounds by non-linear regression analysis of log-concentration-response 171 curves. The 50% inhibitory concentrations (IC 50 ) were determined for each compound. If more 172 than two experiments were performed the mean and standard deviation is given. The 173 coefficient of determination (R 2 ) was calculated to assess correlations. 174
Ethical approval 175
We used three clinical isolates described in a previous study (27) . The study was approved by 176 the ethics committee of the International Foundation for the Albert Schweitzer Hospital in 177
Lambaréné and followed the principles of the Declaration of Helsinki (6 th revision). The 178 participating children and legal representatives gave assent and informed consent, respectively. 179
Results 180
Viability of mature gametocytes and validation of luminescence 181
As a first step, we evaluated first the viability of gametocytes after purification and validated the 182 ATP read out. Gametocytes appeared non-compromised after purification with intact cytoplasm 183 (Table 1) . (Table 2) . However, MitoRed was 3-207 fold more active when used over 48 hours compared to 24 hours. This effect was even more 208 pronounced for epoxomicin and artesunate incubations, with a 10-fold increase in activity when 209 parasites were exposed for 48 hours.
The primary aim of antimalarial treatment is to remove asexual blood stage parasites in order 212 to resolve the illness and prevent or treat severe forms of malaria. In contrast, late stage 213 gametocytes do not cause significant harm to the infected individual and appear in the 214 circulation after a lag period due to sequestration. Most of the current antimalarials act against 215 asexual infection but have no significant effect on sexual stages, which remain in the circulation 216 for extended periods after treatment and could therefore be transmitted (31,32). To achieve 217 sustained malaria control and contain resistance development, an efficient gametocytocidal 218 drug is fundamental. We identified five synthetic dyes with good gametocytocidal activity. When 219 compared to methylene blue, a drug with known gametocytocidal activity (15,23-25), these five 220 dyes were more active, particularly, the three mitochondrial dyes MitoRed, DiOC6 and 221 rhodamine B. Cytotoxicity of the mitochondrial dyes was higher than 2.5 µM when evaluated 222 against HeLa cells in our previous publication (22). MitoRed was the most active compound 223 against gametocytes. Interestingly, we had previously selected it as a promising candidate for 224 development as an antimalarial due to its high activity against asexual blood stage parasites 225 and its favorable selectivity index when tested against HeLa cells. It belongs to the rhodamine 226 dyes. Some of its derivatives are used in the cosmetic industry where toxicity has been more 227 extensively studied (33,34). However, no further toxicity data on MitoRed are available. The 228 results from the current gametocyte assay underline the interesting properties of mitochondrial 229 dyes as starting points for new antimalarials and further toxicity studies of the most promising 230 compounds should be performed. Interestingly, all compounds except epoxomicin showed 231 higher activity against asexual blood stages than against gametocytes. This is likely due to the 232 less active metabolism during the late gametocyte stage. Dyes are selectively targeted to 233 certain organelles in the organism presumably inhibiting the targeted organelle. Interestingly, 234 atovaquone, a potent inhibitor of the cytochrome bc1 complex of the mitochondrion, does not 235 on July 6, 2017 by guest http://aac.asm.org/ Downloaded from affect gametocyte development (8). Nevertheless, mitochondrial dyes are highly active which is 236 most likely because they do not share the same mechanism of action. 237
In addition to P. falciparum 3D7 gametocytes, we used three clinical isolates from Lambaréné, 238
Gabon, an area of high drug pressure and widespread chloroquine and folate inhibitor 239 resistance (35,36). Gametocytes derived from the laboratory strain 3D7 seem to be more 240 sensitive to most compounds than the tested clinical isolates. This finding has important 241 implications for larger screening programs since hits achieved in laboratory isolates should be 242 considered to be validated in clinical isolates. Primaquine presented one exception to this rule 243 because it is more active against clinical isolates than against 3D7. However, the in vitro 244 activity is likely not a good surrogate for the relevant activity of primaquine in vivo, as it has to 245 be metabolized by CYP2D6 (37,38) and MAO-A (38) to be active. Therefore primaquine shows 246 rather unspecific activity in vitro and can only be used as a comparator between assays, 247
showing that our results are in line with results obtained by others (8,30,39) . 248
The difference in activities between clinical isolates and 3D7 was particularly high for 249 artemisinin derivatives. Whether or not this is due to drug pressure may only be hypothesized. 
